Biocon Ltd.

Financial

	Biocon	Concord Biotech	Advanced Enzyme
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	7.7 %	n/a	n/a
R&D as a % of Total Sales	7.0 %	2.26 %	10.41 %
Financials
5 yr Average ROE	5.97 %	20.02 %	10.77 %
5yr average Equity Multiplier	2.64	1.26	1.15
5yr Average Asset Turnover Ratio	0.31	0.52	0.41
5yr Avg Net Profit Margin	7.2 %	30.81 %	22.63 %
Price to Book	2.37	10.04	2.84
P/E	50.53	48.97	30.74
5yr Avg Cash Conversion Cycle	-193.26 Days	37.41 Days	109.31 Days
Inventory Days	102.53 Days	80.96 Days	77.49 Days
Days Receivable	139.43 Days	111.87 Days	61.31 Days
Days Payable	307.82 Days	173.13 Days	49.86 Days
5yr Average Interest Coverage Ratio	8.77	137.55	54.21
5yr Avg ROCE	6.71 %	25.59 %	14.52 %
5yr Avg Operating Profit Margin	19.38 %	42.97 %	35.47 %
5 yr average Debt to Equity	0.75	0.04	0.02
5yr CAGR Net Profit	6.47 %	12.77 %	-2.12 %
5yr Average Return on Assets	2.35 %	15.93 %	9.32 %
Shareholdings
Promoter Holding	54.45 %	44.08 %	43.08 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.19 %	0.0	-9.62 %
Change in Mutual Fund Holding (3 Yrs)	12.19 %	-0.9 %	-0.59 %

Business

	Biocon	Concord Biotech	Advanced Enzyme
Product Wise Break-Up	Product Wise Break-Up Biosimilars 54.39 Generics 23.13 Syngene (Research Services) 22.48 Novel 0 Branded Formulations 0 Biologics 0 Formulations 0 API - Fermentation based 0 Specialized Manufacturing 0 Bio-process 0 Animal nutrition 0 Human nutrition 0	Product Wise Break-Up Syngene (Research Services) 0 Biologics 0 Human nutrition 0 Bio-process 0 Specialized Manufacturing 0 Novel 0 Animal nutrition 0 API - Fermentation based 84.0 Generics 0 Formulations 16.0 Biosimilars 0 Branded Formulations 0	Product Wise Break-Up Syngene (Research Services) 0 Biologics 0 Human nutrition 64.0 Bio-process 16.0 Specialized Manufacturing 8.0 Novel 0 Animal Health 12.0 API - Fermentation based 0 Generics 0 Formulations 0 Biosimilars 0 Branded Formulations 0
Location Wise Break-Up	Location Wise Break-Up USA 46.14 Ireland 25.21 Rest of the World 22.24 India 6.4 Asia (Ex India) 0 Europe 0 Others 0.01	Location Wise Break-Up India 56.0 USA 0 Europe 0 Asia (Ex India) 0 Rest of the World 44.0 Ireland 0	Location Wise Break-Up India 46.0 USA 37.0 Europe 5.0 Asia Pacific 9.0 Rest of the World 0 Ireland 0 Others 3.0
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Asset Break-Up	Asset Break-Up Biosimilars 74.61 Generics 13.98 Research 11.41 Novel Biologics 0 India 0 USA 0 Europe 0	Asset Break-Up India 99.74 USA 0 Europe 0 Research 0 Novel Biologics 0 Generics 0 Biosimilars 0 Others 0.26	Asset Break-Up India 48.73 USA 43.08 Europe 8.2 Research 0 Novel Biologics 0 Generics 0 Biosimilars 0

Biocon Ltd.

SIGN UP FOR FREE